Literature DB >> 1439207

Comparative behaviour of Brucella abortus strains 19 and RB51 in the pregnant mouse.

L Tobias1, G G Schurig, D O Cordes.   

Abstract

Pregnant BALB/c mice received various doses of either Brucella abortus strain 19, a smooth vaccine strain, or B abortus strain RB51, a stable rough organism, intraperitoneally on day 9 of gestation to compare the relative pathogenicity of the two attenuated strains. Nine days after inoculation, spleens and placentas were collected for bacteriological and histopathological examination. A dose of 10(7.5) and strain 19 organisms produced a severe necrosuppurative placentitis occasionally accompanied by fetal death. This dose resulted in a 10-fold higher level of splenic infection than did a dose of 10(9.5) strain RB51 organisms, which produced only mild to minimal placentitis not associated with fetal death. Strain 19 infected mice showed seroconversion in the standard tube agglutination test in contrast to the seronegative titre of strain RB51 infected mice. The results of this study corroborate previous investigations on the relative pathogenicity and the serological response of the non-pregnant mouse to strain RB51.

Entities:  

Mesh:

Year:  1992        PMID: 1439207     DOI: 10.1016/0034-5288(92)90107-d

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  8 in total

1.  Immune and pathologic responses in mice infected with Brucella abortus 19, RB51, or 2308.

Authors:  M G Stevens; S C Olsen; G W Pugh; M V Palmer
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

2.  Comparison of immune responses and resistance to brucellosis in mice vaccinated with Brucella abortus 19 or RB51.

Authors:  M G Stevens; S C Olsen; G W Pugh; D Brees
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

3.  Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis.

Authors:  M P Jiménez de Bagüés; P H Elzer; S M Jones; J M Blasco; F M Enright; G G Schurig; A J Winter
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

4.  Brucella abortus and Pregnancy in Mice: Impact of Chronic Infection on Fertility and the Role of Regulatory T Cells in Tissue Colonization.

Authors:  Shakirat A Adetunji; Denise L Faustman; L Garry Adams; Daniel G Garcia-Gonzalez; Martha E Hensel; Omar H Khalaf; Angela M Arenas-Gamboa
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

5.  Enhancement of the Brucella AMOS PCR assay for differentiation of Brucella abortus vaccine strains S19 and RB51.

Authors:  B J Bricker; S M Halling
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

6.  Vaccination with Brucella abortus recombinant in vivo-induced antigens reduces bacterial load and promotes clearance in a mouse model for infection.

Authors:  Jake E Lowry; Dale D Isaak; Jack A Leonhardt; Giulia Vernati; Jessie C Pate; Gerard P Andrews
Journal:  PLoS One       Date:  2011-03-11       Impact factor: 3.240

7.  Immune Response of Calves Vaccinated with Brucella abortus S19 or RB51 and Revaccinated with RB51.

Authors:  Elaine M S Dorneles; Graciela K Lima; Andréa Teixeira-Carvalho; Márcio S S Araújo; Olindo A Martins-Filho; Nammalwar Sriranganathan; Hamzeh Al Qublan; Marcos B Heinemann; Andrey P Lage
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

8.  Screening of potential vaccine candidates against pathogenic Brucella spp. using compositive reverse vaccinology.

Authors:  Xiaodong Zai; Ying Yin; Fengyu Guo; Qiaoling Yang; Ruihua Li; Yaohui Li; Jun Zhang; Junjie Xu; Wei Chen
Journal:  Vet Res       Date:  2021-06-02       Impact factor: 3.683

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.